Guangdong Hybribio Biotech Co.,Ltd.

SZSE:300639.SZ

8.67 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 1,104.4545,596.9712,673.0231,354.497729.393580.352479.085398.304344.834264.083182.718139.014
Cost of Revenue 430.4171,714.664865.181360.753141.58695.77978.57757.07341.79136.21732.56531.698
Gross Profit 674.0373,882.3071,807.842993.743587.807484.573400.508341.231303.043227.866150.152107.317
Gross Profit Ratio 0.610.6940.6760.7340.8060.8350.8360.8570.8790.8630.8220.772
Reseach & Development Expenses 136.322247.281115.29471.62257.44745.9533.55931.87331.5117.70520.37719.019
General & Administrative Expenses 88.756143.23888.81867.32756.42450.43338.90520.7919.29515.48544.21936.992
Selling & Marketing Expenses 279.123460.212382.676313.111260.448217.545183.119159.989143.027101.46168.42648.184
SG&A 367.879603.45471.494380.438316.873267.978222.023180.778162.322116.946112.64585.176
Other Expenses 127.236256.634114.34966.03163.126-0.076-0.5694.493.1480.7990.3191.047
Operating Expenses 631.4371,107.365701.137518.091437.445367.432295.628257.811228.997154.569114.1886.177
Operating Income 42.62,193.171,073.78468.84156.253126.014110.06580.42971.96272.10833.14521.325
Operating Income Ratio 0.0390.3920.4020.3460.2140.2170.230.2020.2090.2730.1810.153
Total Other Income Expenses Net -4.941-65.304-16.599-4.86415.456-0.0767.9644.4690.104-0.496-0.0221.232
Income Before Tax 37.6592,127.8661,057.181463.976154.523125.939109.49684.89974.1572.80133.12322.371
Income Before Tax Ratio 0.0340.380.3960.3430.2120.2170.2290.2130.2150.2760.1810.161
Income Tax Expense -31.698326.464172.24469.31917.56719.19617.73310.3359.7349.3423.9532.647
Net Income 140.4721,725.998852.16362.662147.291114.0893.2176.09565.21263.45929.1719.725
Net Income Ratio 0.1270.3080.3190.2680.2020.1970.1950.1910.1890.240.160.142
EPS 0.252.651.30.590.250.190.170.170.140.150.0730.046
EPS Diluted 0.252.651.30.590.250.190.170.170.140.150.0730.046
EBITDA 236.0822,331.9921,151.883514.819195.744166.73144.255105.51285.82684.73738.04622.184
EBITDA Ratio 0.2140.5220.4490.3910.2750.2780.2930.2810.2640.3270.2080.16